P
Priya Abraham
Researcher at Indian Council of Medical Research
Publications - 196
Citations - 3342
Priya Abraham is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Medicine & Hepatitis B virus. The author has an hindex of 28, co-authored 151 publications receiving 2272 citations. Previous affiliations of Priya Abraham include Christian Medical College & Hospital & National Institute of Virology.
Papers
More filters
Journal ArticleDOI
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
Raches Ella,Siddarth Reddy,William C. Blackwelder,Varsha Potdar,Pragya D Yadav,Vamshi Sarangi,Vinay Kumar Aileni,Suman Kanungo,Sanjay K Rai,P. Prabhakar Reddy,Savita Verma,Chandramani Singh,Sagar Vivek Redkar,Satyajit Mohapatra,Anil Pandey,Pajanivel Ranganadin,Raghavendra Gumashta,Manish Multani,Shameem Mohammad,Parul Bhatt,Laxmi Kumari,Gajanan Sapkal,Nivedita Gupta,Priya Abraham,Samiran Panda,Sai Prasad,Balram Bhargava,Krishna Murthy Ella,Krishna Mohan Vadrevu +28 more
TL;DR: In this article, the authors reported the clinical efficacy against COVID-19 infection of BBV152, a whole virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist molecule adsorbed to alum (Algel-IMDG) in Indian adults.
Journal ArticleDOI
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees.
Pragya D Yadav,Gajanan N. Sapkal,Priya Abraham,Raches Ella,Gururaj Rao Deshpande,Deepak Y. Patil,Dimpal A Nyayanit,Nivedita Gupta,Rima R Sahay,Anita M. Shete,Samiran Panda,Balram Bhargava,V Krishna Mohan +12 more
TL;DR: In this paper, the authors used convalescent sera of COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.
Journal ArticleDOI
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease.
Jeyamani Ramachandran,Chundamannil E. Eapen,Gagandeep Kang,Priya Abraham,Darius D. J. Hubert,George Kurian,Julie Hephzibah,Ashis Mukhopadhya,George Chandy +8 more
TL;DR: The clinical profile and outcome of patients with chronic liver disease and hepatitis E virus (HEV) superinfection, and the seroprevalence of hepatitis A and E infections in patients and controls in India are examined.
Posted ContentDOI
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
Pragya D Yadav,Gajanan N. Sapkal,Priya Abraham,Raches Ella,Gururaj Rao Deshpande,Deepak Y. Patil,Dimpal A Nyayanit,Nivedita Gupta,Rima R Sahay,Anita M. Shete,Samiran Panda,Balram Bhargava,V Krishna Mohan +12 more
TL;DR: In this paper, the authors used convalescent sera of COVID-19 cases and recipients of BBV152 (Covaxin) were able to neutralize VUI B.1.617.
Journal ArticleDOI
Distribution of Hepatitis B Virus Genotypes in Blood Donors and Chronically Infected Patients in a Tertiary Care Hospital in Southern India
Perumal Vivekanandan,Priya Abraham,Gopalan Sridharan,George Chandy,Dolly Daniel,Sukanya Raghuraman,Hubert Darius J. Daniel,Thenmozhi Subramaniam +7 more
TL;DR: In this paper, the hepatitis B virus (HBV) genotypes differ in their potential for causing disease and the ratio of male to female subjects was significantly higher in the blood donor group than in the group of patients with CHBV (P=.0004).